Literature DB >> 15147675

Cross-species regulation of Plasmodium parasitaemia cross-examined.

Georges Snounou1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15147675     DOI： 10.1016/j.pt.2004.03.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


× No keyword cloud information.
  5 in total

1.  A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.

Authors:  Paulo Afonso Nogueira; Fabiana Piovesan Alves; Carmen Fernandez-Becerra; Oliver Pein; Neida Rodrigues Santos; Luiz Hildebrando Pereira da Silva; Erney Plessman Camargo; Hernando A del Portillo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 3.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

4.  Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes.

Authors:  Laurin J Kasehagen; Ivo Mueller; Benson Kiniboro; Moses J Bockarie; John C Reeder; James W Kazura; Will Kastens; David T McNamara; Charles H King; Christopher C Whalen; Peter A Zimmerman
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

5.  Cryptic Plasmodium ovale concurrent with mixed Plasmodium falciparum and Plasmodium malariae infection in two children from Central African Republic.

Authors:  Cynthia Bichara; Philippe Flahaut; Damien Costa; Anne-Lise Bienvenu; Stephane Picot; Gilles Gargala
Journal:  Malar J       Date:  2017-08-15       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.